Onderneming Wockhardt Bio AG
Aandelen
WBIO
CH0193042501
Farmaceutische producten
Vakgebied
Aantal werknemers: 50
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ajay Sahni
CEO | Chief Executive Officer | 57 | 01-01-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 85 | 01-04-19 | |
Ajay Sahni
CEO | Chief Executive Officer | 57 | 01-01-08 |
Ravi Limaye
BRD | Director/Board Member | 60 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 51 948 000 | 51 428 520 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Laboratoires Negma SAS
Laboratoires Negma SAS Pharmaceuticals: MajorHealth Technology Laboratoires Negma SAS manufactures pharmaceutical products. It has products in the osteoarthritis, anti-hemorrhoids, anti-hypertension, rheumatology, phlebotonic, and vesical instability. The company also has manufacturing facilities in Europe. Laboratoires Negma S.A.S. was formerly known as Negma Lerads S.A.S. the company was founded in 1996 and is headquartered in Velizy Villacoublay, France |
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,63% | 44,12 mld. | |
+22,99% | 22,71 mld. | |
+18,22% | 15,15 mld. | |
+12,66% | 13,61 mld. | |
+60,18% | 13,34 mld. | |
-8,35% | 6,84 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+12,92% | 5,63 mld. |